We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Crown Place Vct Plc | LSE:CRWN | London | Ordinary Share | GB0002577434 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 28.90 | 28.40 | 29.40 | 28.90 | 28.90 | 28.90 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 4.78M | 2.82M | 0.0100 | 28.90 | 81.13M |
TIDMCRWN
Crown Place VCT PLC
Interim Management Statement
LEI Code: 213800SYIQPA3L3T1Q68
Introduction
I am pleased to present Crown Place VCT PLC's interim management statement for the period from 1 January 2022 to 31 March 2022.
Performance and dividends
The Company's unaudited net asset value (NAV) as at 31 March 2022 was GBP86.0 million or 33.71 pence per share (excluding treasury shares). After accounting for a dividend of 0.84 pence per share which was paid on 31 March 2022 to shareholders on the register on 11 March 2022 the NAV has increased by 0.79 pence per share (2.4 per cent.) since 31 December 2021.
Fundraising and share issues
During the period from 1 January 2022 to 31 March 2022, the Company issued the following new Ordinary shares of nominal value 1 penny per share under the Albion VCTs Prospectus Top Up Offers 2021/22:
Issue price per share Number of shares (including costs of Net proceeds Date issued issue) GBP'000 ----------------- ---------------------- --------------------- ------------ 25 February 2022 30,665,580 34.30p to 34.70p 10,374 ----------------- ---------------------- --------------------- ------------ 31 March 2022 1,838,353 33.80p 606 ----------------- ---------------------- --------------------- ------------
On 2 March 2022, the Company announced that applications under the Prospectus offer had reached its GBP12 million gross limit and was therefore fully subscribed and closed to further applications.
The Company also issued the following shares under the dividend reinvestment scheme which are included in the net asset value figures for 31 March 2022 above:
Net invested Date Number of shares issued Issue price per share GBP'000 -------------- ----------------------- --------------------- ------------ 31 March 2022 1,137,670 32.92 pence 357 -------------- ----------------------- --------------------- ------------
The Company continues to offer a Dividend Reinvestment Scheme to existing shareholders. Details of this Scheme can be found at www.albion.capital/funds/CRWN.
Portfolio
The following investments have been made during the period from 1 January 2022 to 31 March 2022:
New investments GBP'000 Activity ----------------- ------- -------------------------------------------------- Perchpeek Limited 672 Digital relocation platform ----------------- ------- -------------------------------------------------- Regulatory Genome Development Provider of machine readable structured regulatory Limited 116 content ----------------- ------- -------------------------------------------------- Total further investments 788 ----------------- ------- Further investments GBP'000 Activity ------------------- ------- -------------------------------------------------------- A provider of a connectivity solution, connecting financial institutions with trading venues via a single TransFICC Limited 846 API ------------------- ------- -------------------------------------------------------- Seldon Technologies Software company that enables enterprises to deploy Limited 615 Machine Learning models in production ------------------- ------- -------------------------------------------------------- Cantab Research Provider of low footprint automated speech recognition Limited (T/A which can be deployed in the cloud, on premise or Speechmatics) 445 on device across over 31 languages ------------------- ------- -------------------------------------------------------- Black Swan Data Limited 336 Predictive analytics for consumer brands ------------------- ------- -------------------------------------------------------- Nuvoair Holdings Digital therapeutics and decentralised clinical trials Inc. 152 for respiratory conditions ------------------- ------- -------------------------------------------------------- Koru Kids Limited 83 Online marketplace connecting parents and nannies ------------------- ------- -------------------------------------------------------- Locum's Nest Provides a technology solution for the management Limited 82 of locum doctors for the NHS ------------------- ------- -------------------------------------------------------- Total further investments 2,559 ------------------- -------
Disposals
The following disposals were made during the period from 1 January 2022 to 31 March 2022:
Portfolio Company GBP000s ----------------- ------- -------------------------------------------------- Credit Kudos Disposal of investment on a cost of GBP0.5 million Limited 2,352 realising a gain of GBP1.9 million on cost ----------------- ------- -------------------------------------------------- Disposal of investment on a cost of GBP0.6 million Phrasee Limited 1,991 realising a gain of GBP1.4 million on cost ----------------- ------- -------------------------------------------------- Disposal of investment on a cost of GBP0.5 million MyMeds&Me Limited 1,476 realising a gain of GBP1.0 million on cost ----------------- ------- -------------------------------------------------- Total proceeds 5,819 ----------------- -------
Top ten holdings as at 31 March 2022:
% of net Carrying value asset Investment GBP'000 value Activity ------------------- -------------- ----- ---------------------------------------------------------- Quantexa Limited 10,119 11.8 Network analytics platform to detect financial crime ------------------- -------------- ----- ---------------------------------------------------------- Proveca Limited 3,993 4.6 Reformulation of paediatric medicines ------------------- -------------- ----- ---------------------------------------------------------- Technology enabled service business in medical nutritional Oviva AG 3,634 4.2 therapy (MNT) ------------------- -------------- ----- ---------------------------------------------------------- Chonais River Hydro Owner and operator of a 2 MW hydro-power scheme in Limited 3,276 3.8 the Scottish Highlands ------------------- -------------- ----- ---------------------------------------------------------- Radnor House School (TopCo) Limited 3,145 3.7 Independent school for children aged 2-18 ------------------- -------------- ----- ---------------------------------------------------------- The Evewell Group Operator and developer of women's health centres focusing Limited 2,415 2.8 on fertility ------------------- -------------- ----- ---------------------------------------------------------- Cantab Research Provider of low footprint automated speech recognition Limited (T/A which can be deployed in the cloud, on premise or Speechmatics) 1,923 2.2 on device across 31 languages ------------------- -------------- ----- ---------------------------------------------------------- Gharagain River Owner and operator of a 1 MW hydro-power scheme in Hydro Limited 1,793 2.1 the Scottish Highlands ------------------- -------------- ----- ---------------------------------------------------------- Elliptic Enterprises Provider of Anti Money Laundering services to digital Limited 1,529 1.8 asset institutions ------------------- -------------- ----- ---------------------------------------------------------- Black Swan Data Limited 1,355 1.6 Predictive analytics for consumer brands ------------------- -------------- ----- ----------------------------------------------------------
Share buy-backs
During the period from 1 January 2022 to 31 March 2022, the Company purchased 2,022,762 shares for GBP636,000 including stamp duty, at an average price of 31.27 pence per share. All of the shares are to be held in treasury.
It remains the Board's policy to buy back shares in the market, subject to the overall constraint that such purchases are in the Company's interest, including the maintenance of sufficient resources for investment in existing and new portfolio companies and the continued payment of dividends to shareholders.
It is the Board's intention for such buy-backs to be at around a 5 per cent. discount to net asset value, so far as market conditions and liquidity permit.
Material events and transactions after the period end
After the period end, the Company undertook the following material investment transaction:
-- Investment of GBP532,000 in an existing portfolio company, Gravitee Topco Limited, an open source API management platform.
The following new Ordinary shares of nominal value 1 penny each were allotted under the Albion VCTs Prospectus Top Up Offers 2021/22 to shareholders who elected for the 2022/23 tax year:
Issue price per share (including costs of Net proceeds Date Number of shares issued issue) GBP'000 -------------- ----------------------- ----------------------- ------------ 11 April 2022 2,215,278 33.50p to 33.80p 730 -------------- ----------------------- ----------------------- ------------
There have been no other material events or transactions after the period end to the date of this announcement.
Further information
Further information regarding historic and current financial performance and other useful shareholder information can be found on the Company's webpage on the Manager's website at www.albion.capital/funds/CRWN.
Penny Freer, Chairman
crownchair@albion.capital
17 May 2022
For further information please contact:
Vikash Hansrani
Operations Partner
Albion Capital Group LLP
Telephone: 020 7601 1850
(END) Dow Jones Newswires
May 17, 2022 06:58 ET (10:58 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Crown Place Vct Chart |
1 Month Crown Place Vct Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions